Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient

Detalles Bibliográficos
Autores principales: Morales, Enrique, Morales, Rafael, Gutiérrez, Eduardo, Rojas-Rivera, Jorge, Praga, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Educational Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400569/
https://www.ncbi.nlm.nih.gov/pubmed/26069815
http://dx.doi.org/10.1093/ckj/sfs150
_version_ 1782367049191784448
author Morales, Enrique
Morales, Rafael
Gutiérrez, Eduardo
Rojas-Rivera, Jorge
Praga, Manuel
author_facet Morales, Enrique
Morales, Rafael
Gutiérrez, Eduardo
Rojas-Rivera, Jorge
Praga, Manuel
author_sort Morales, Enrique
collection PubMed
description
format Online
Article
Text
id pubmed-4400569
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-44005692015-06-11 Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient Morales, Enrique Morales, Rafael Gutiérrez, Eduardo Rojas-Rivera, Jorge Praga, Manuel Clin Kidney J Educational Papers Oxford University Press 2012-12 2012-11-09 /pmc/articles/PMC4400569/ /pubmed/26069815 http://dx.doi.org/10.1093/ckj/sfs150 Text en © The Author 2012. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For permissions, please email: journals.permissions@oup.com. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Educational Papers
Morales, Enrique
Morales, Rafael
Gutiérrez, Eduardo
Rojas-Rivera, Jorge
Praga, Manuel
Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient
title Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient
title_full Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient
title_fullStr Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient
title_full_unstemmed Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient
title_short Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient
title_sort raloxifene and bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient
topic Educational Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400569/
https://www.ncbi.nlm.nih.gov/pubmed/26069815
http://dx.doi.org/10.1093/ckj/sfs150
work_keys_str_mv AT moralesenrique raloxifeneandbevacizumabforseverecomplicationsofhereditaryhaemorrhagictelangiectasiainahaemodialysispatient
AT moralesrafael raloxifeneandbevacizumabforseverecomplicationsofhereditaryhaemorrhagictelangiectasiainahaemodialysispatient
AT gutierrezeduardo raloxifeneandbevacizumabforseverecomplicationsofhereditaryhaemorrhagictelangiectasiainahaemodialysispatient
AT rojasriverajorge raloxifeneandbevacizumabforseverecomplicationsofhereditaryhaemorrhagictelangiectasiainahaemodialysispatient
AT pragamanuel raloxifeneandbevacizumabforseverecomplicationsofhereditaryhaemorrhagictelangiectasiainahaemodialysispatient

Ejemplares similares